Summary
This 8-K filing by priceline.com Incorporated (now Booking Holdings Inc.) on December 5, 2007, primarily details the granting of performance share units to two key non-U.S. executives: Stef Norden, President and CEO of priceline.com International Limited, and Jan Docter, a Director and consultant to Booking.com B.V. These awards are designed to incentivize long-term performance and retention, with vesting contingent upon specific financial targets (cumulative adjusted EBITDA for Priceline Europe) and continued employment through March 1, 2011. Investors should note that this filing is focused on executive compensation and aligns executive interests with the company's performance, particularly within its European operations. The structure of these performance share units emphasizes a three-year performance period (2008-2010) and requires continued service, suggesting a strategic effort to retain key talent driving international growth. While specific financial targets are not disclosed publicly, the linkage to adjusted EBITDA signals a focus on profitability and operational efficiency within Priceline Europe.
Key Highlights
- 1Priceline.com Incorporated (BKNG) granted 25,000 performance share units to Stef Norden (President & CEO, Priceline Europe) and 5,000 to Jan Docter (Director & consultant, Booking.com B.V.).
- 2These performance share units are payable in the company's common stock.
- 3Vesting is conditional upon Priceline Europe achieving certain performance targets based on cumulative adjusted EBITDA from January 1, 2008, to December 31, 2010.
- 4Both executives must remain employed through March 1, 2011, to receive the shares, barring specific exceptions (change in control, termination for cause, death, or disability).
- 5The awards are granted under the priceline.com 1999 Omnibus Plan, a stockholder-approved plan.
- 6The company intends to grant substantially similar performance share unit awards to other non-U.S. executive officers in the future.
- 7This filing includes the form of the performance share unit agreement as an exhibit, with certain portions omitted under a confidential treatment request.